We are live on
!
Find out more
Bristol-Myers Squibb
BMY
BMY
1,575 hedge funds and large institutions have $90.9B invested in Bristol-Myers Squibb in 2016 Q2 according to their latest regulatory filings, with 114 funds opening new positions, 576 increasing their positions, 640 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 1,522 → 1,575 (+53)
1.35% less ownership
Funds ownership: 75.29% → 73.94% (-1.4%)
10% less repeat investments, than reductions
Existing positions increased: 576 | Existing positions reduced: 640
Holders
1,575
Holding in Top 10
110
Calls
$785M
Puts
$647M
Top Buyers
| 1 | +$495M | |
| 2 | +$397M | |
| 3 | +$254M | |
| 4 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
+$94.3M |
| 5 |
JFL
Jarislowsky, Fraser Ltd
Montreal,
Quebec, Canada
|
+$94.1M |
Top Sellers
| 1 | -$1.81B | |
| 2 | -$517M | |
| 3 | -$376M | |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$209M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$209M |